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Abstract
Objectives: To compare in persons aged 70 years or older the clinical and inflammatory changes
occurring around implants and natural teeth during and after a phase of undisturbed plaque
accumulation.
Material and methods: Twenty partially edentulous participants with titanium implants refrained
from oral hygiene practices while being clinically monitored in weekly intervals for 21 days. Teeth
and implants were then cleaned, oral hygiene resumed, and the participants were further
monitored for 3 weeks. Twelve biomarkers were assessed in gingival and peri-implant crevicular
fluid (GCF, PCF).
Results: During 3 weeks of oral hygiene abstention, the gingival index (GI) continuously increased.
On day 21, there were significantly more sites with GI >1 at implants than at teeth. After restarting
oral hygiene, the GI decreased markedly in both groups. Throughout the experiment, the plaque
index was significantly higher on teeth than on implants.The different biomarkers reacted variably.
IL-1b increased significantly with plaque accumulation. IL-1b, GM-CSF, TNF-a, and IFN-c were
significantly higher in GCF compared to PCF at day 21. IL-8 decreased significantly in GCF up to day
14. MIP-1b decreased significantly in GCF, but not in PCF. At the 3-week follow-up, the levels of all
biomarkers assessed in GCF and PCF had returned to baseline values.
Conclusions: In an elderly cohort, plaque accumulation induced an inflammatory reaction around
both teeth and implants. Although there was less plaque accumulation on implants, the peri-
implant mucosa showed a stronger clinical response than gingiva.
In 1965, a groundbreaking publication (L€oe
et al. 1965) demonstrated for the first time
convincingly that the accumulation of bacte-
rial deposits on teeth can cause inflammation
in the gingiva. Twelve young volunteers with
relatively healthy gingiva were asked not to
clean their teeth anymore. In the absence of
oral hygiene, bacterial deposits formed on the
teeth, initially detectible only after moving a
dental instrument on the tooth surface, later
recognizable with the naked eye as a layer of
soft matter. Within 9–21 days, the gingiva
started to show signs of inflammation such
as redness, change in texture, and bleeding
on pressure. Once the inflammation was
established, detailed instructions were given
to the participants to clean the teeth again
properly. As a consequence of the bacterial
deposits being removed, the inflammation of
the gingiva disappeared. Other investigators
have repeated this experiment in diverse
human cohorts and with various modifica-
tions, corroborating the general association
between poor oral hygiene and inflammation
(Theilade 1996). The effect of plaque on
implants on the peri-implant mucosa has
also been studied. Reports indicated that
accumulation of bacterial deposits on
implants induced inflammation in the peri-
implant mucosa in a similar way as dental
plaque produced gingivitis (Pontoriero et al.
1994; Zitzmann et al. 2001). A more recent
study concluded that the inflammatory
response seemed to be even stronger in the
peri-implant mucosa than in the gingiva
(Salvi et al. 2012). Heterogeneity in the devel-
opment of clinical signs of gingivitis had
already been noted by L€oe et al. and was ini-
tially thought to be due to differences in
either the plaque volume or the microbial
composition (Theilade et al. 1966). Today, it
is recognized that the gingival inflammation
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may also depend on host factors modulating
the inflammatory response to the presence of
bacteria (Hajishengallis & Lamont 2012).
Good oral hygiene is not a common finding
among elderly people (Kay & Locker 1996).
Even though the prevalence of gingivitis var-
ied among the different populations studied,
it was suggested that the majority of the
elderly patients had a tendency for a more
severely inflamed gingiva (MacEntee 2005).
Following the original report of a cause-and-
effect relationship between dental plaque and
gingivitis, the effect of age on the develop-
ment of experimental gingivitis was evalu-
ated (Fransson et al. 1996). Although the
elderly participants showed similar amounts
of plaque as the young subjects, they devel-
oped more gingivitis. Substantial age-asso-
ciated abnormalities in the immune cell-
response, that is, neutrophils, macrophages,
dendritic cells, and Langerhans cells, may
contribute to the increased susceptibility of
the aged individuals to periodontal disease
(Zavala & Cavicchia 2006).
The analysis of the gingival crevicular fluid
(GCF) composition is a non-invasive method
to assess the inflammatory conditions of the
periodontal tissues (Cimasoni 1983). In anal-
ogy, various molecules have been analyzed in
the peri-implant crevicular fluid (PCF). Levels
of several biomarkers differed with regard to
the clinical status of the gingiva and peri-
implant mucosa (Plagnat et al. 2002;
Nogueira-Filho et al. 2014; Hall et al. 2015;
Recker et al. 2015).
Only few studies have assessed the influ-
ence of plaque accumulation on clinical
parameters and host-derived factors in elderly
individuals. Therefore, the aim of this study
was to compare in persons aged 70 years or
older, the clinical and inflammatory changes
occurring around implants and natural teeth
during a phase of undisturbed plaque accu-
mulation and after reinstitution of mechani-
cal plaque control.
Material and methods
This was a single-center, three-phase experi-
mental gingivitis/mucositis trial, with intra-
patient comparison. The Ethical Committee
of the University Hospitals of Geneva, Gen-
eva, Switzerland, approved the study proto-
col. The study was conducted according to
the principles outlined in the Declaration of
Helsinki on human medical experimentation.
All participants were informed about the pro-
cedures and signed a consent form in advance
of their inclusion in the study.
Participants
Twenty-one participants were recruited
between January 2014 and May 2015 from
patients previously treated at the University
of Geneva School of Dental Medicine. The
clinical procedures and evaluations were car-
ried out between June 2014 and July 2015.
The participants were included based on
the following criteria: aged 70 years or older,
partially edentulous with presence of tita-
nium implants, in good general and oral
health. We excluded patients with peri-
implantitis and/or periodontitis, specifically
those with periodontal or peri-implant pock-
ets deeper than 4 mm with bleeding or pus,
with major systemic illnesses (level P3 and
higher according to the ASA classification;
Dripps et al. 1961), specifically those with
uncontrolled diabetes mellitus, cancer, bone
metabolic diseases, or disorders that compro-
mise wound healing, radiation, or immuno-
suppressive therapy, those with evidence for
an infection in the upper respiratory, pul-
monary, digestive, or renal tract in the last
2 weeks, systemic antibiotics taken within
the previous 2 months, or systemic non-ster-
oidal anti-inflammatory drugs in the previous
month, and heavy smokers (≥20 cigarettes/
day).
Clinical protocol
The study had three parts: In the first
phase, bacterial deposits were removed from
all teeth and implants, and detailed oral
hygiene instructions were given to all par-
ticipants. The ability to perform proper pla-
que control was assessed after one, two, and
3 weeks. If necessary, further instructions
were given, and additional visits were
scheduled. A full-mouth plaque score (PS,
percentage of sites with plaque, four sites
per tooth or implant, detected when run-
ning a probe across a site) <20% was
required to enter the next stage. In the sec-
ond phase, the participants refrained from
oral hygiene practices while being moni-
tored in weekly intervals for 3 weeks. At
the beginning of the third phase, the accu-
mulated bacterial deposits were removed
and instructions were given to clean teeth
and implants again properly. The partici-
pants were further monitored after one and
3 weeks. A minimum of nine visits was
necessary to complete the study.
One calibrated examiner (S.M.) performed
all procedures involving a contact with the
participants. These included patient enroll-
ment, tooth cleaning and oral hygiene
instructions, clinical measurements, and
sampling of GCF and PCF. Two implants
and two teeth were selected at the begin-
ning of the study for longitudinal monitor-
ing and fluid sampling. If present, the first
premolar on each side was selected in the
partially edentulous arch. If the first premo-
lar was missing, the next adjacent mesial
tooth was selected. The following clinical
parameters were recorded: Plaque index (PI)
(Silness & L€oe 1964), gingival index (GI)
(L€oe & Silness 1963), probing depth (PD),
recession (REC; positive if gingival margin
located apical, negative if located coronal to
the cemento-enamel junction or implant
shoulder), bleeding on probing (BOP). The
GI was originally defined to assess natural
teeth, not implants; hence, the modified
sulcus bleeding index (Mombelli et al. 1987)
would have been more suitable for assessing
implants. However, as implants were com-
pared to natural teeth in this study, utiliza-
tion of GI for implants was considered
more appropriate. The clinical parameters
were measured at six sites per unit. The
assessments were made as shown in
Table 1.
Samples of GCF and PCF were obtained
from the mesio-vestibular and disto-lingual/
palatal aspects of the study teeth and
implants. Prior to sampling, the area of col-
lection was isolated with cotton rolls. Each
specific site was cleaned locally with a cot-
ton pellet and dried with an aspiration tip.
After 2 min, a 2 9 6 mm strip of Durapore
membrane, pore size of 0.22 lm (Millipore,
Bedford, MA, USA), was placed at the
entrance of the crevice and left for 30 s to
collect the newly formed fluid. The two
strips from one tooth or implant were put
together into one microtube. Specimens were
stored at 20°C until analyzed.
Laboratory procedures
Biomarkers in GCF and PCF were assessed
using a multiplex fluorescent bead-based
immunoassay and the Bio-Plex 200 suspen-
sion array system (Bio-Rad Laboratories,
Hercules, CA, USA) as previously described
(Cionca et al. 2016). Twelve inflammatory
markers were measured: Interleukin (IL)-1b,
IL-1 receptor antagonist (IL-1ra), IL-6, IL-8,
IL-17, basic fibroblast growth factor (basic-
FGF), granulocyte colony-stimulating factor
(G-CSF), granulocyte–macrophage colony-
stimulating factor (GM-CSF), interferon-c
(IFN-c), macrophage inflammatory protein-1b
(MIP-1b), tumor necrosis factor-a (TNF-a),
vascular endothelial growth factor (VEGF).
The detection limit of the assay varied
between 1.0 and 2.2 pg/ml, except for IL-1ra
(5.6 pg/ml) and TNF-a (6.6 pg/ml).
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Statistical analysis
The Bio-Plex Manager Software 3.0 (BIO-
RAD, Hercules, CA, USA) was used for bio-
chemical data acquisition and processing. A
constant (0.1) was added to all readings to
remove zero values. For all data recorded at
teeth and implants at multiple sites (PI, GI,
PD, REC, BOP), an individual average was
calculated for teeth and implants for each
visit. For part of the analysis, the GI scores
were dichotomized into no or slight gingivitis
without bleeding (scores 0 and 1) vs. marked
gingivitis with bleeding (scores 2 and 3),
referred to as GI >1. Differences between
teeth and implants at specific visits, and lon-
gitudinal changes within each group, were
analyzed with the Wilcoxon signed-rank test.
The significance threshold was set at 0.05.
The statistical software R (version 3.2.2, The
R Foundation for Statistical Computing,
Vienna, Austria) was used for the analyses.
Results
Twenty-one persons gave informed consent
and were enrolled in the study. One partici-
pant was lost after the second visit due to
difficulties to travel. All other participants,
10 males and 10 females, attended all visits
and completed the study according to proto-
col. Their mean age was 77.0  5.7 years
(range 70–88 years). None of the participants
was a current smoker. The mean number of
teeth per person was 16.2  5.9. The mean
number of implants was 4.1  2.4. All study
implants except one (Axiom, Anthogyr SAS,
Sallanches, France) were from the same man-
ufacturer (Institut Straumann AG, Basel,
Switzerland) and had a sandblasted and acid-
etched titanium surface (SLA). They had been
placed at various time points at least 1 year
before the study. Twenty-one of the study
implants supported single-unit crowns, 12
implants supported fixed bridges, 7 carried a
retentive anchor. Seven of the study teeth
were without restoration, 24 had a composite
filling, and 9 were crowned.
Table 2 shows the clinical and biological
characteristics of the selected study teeth and
implants at baseline. There was a significant
difference between implants and teeth for
mean PI, mean PD, and mean REC. Differ-
ences between readings of biomarkers were
not statistically significant.
Figure 1 shows the intra-oral status of one
participant after 21 days of no oral hygiene.
Table 3 shows the clinical parameters before,
during (days 7, 14, 21) and after plaque accu-
mulation (days 28, 42). After 1 week without
oral hygiene (day 7), implants and teeth had a
significantly increased mean PI. The PI
increased further to reach the highest value
on day 21. After reinstituting oral hygiene,
the PI decreased markedly in both groups.
Figure 2 shows the average proportion of
sites with a PI score of 1, 2, and 3 around
teeth and implants. Throughout the experi-
ment, PI was significantly higher on teeth
than on implants.
During 3 weeks of oral hygiene abstention,
the GI continuously increased, reaching a
level statistically higher than at day 0 on day
14 on both teeth and implants. On day 21,
there were significantly more sites with GI
>1 at implants than at teeth. After resuming
oral hygiene, the GI decreased markedly in
both groups. There was a tendency for a more
severe inflammation around implants com-
pared to teeth, with higher proportions of
sites with GI >1. At implants, GI >1 was still
higher than baseline on day 28, and signifi-
cantly higher compared to teeth. Figure 3
shows the average proportion of sites with a
GI score of 1, 2, and 3 around teeth and
implants. At day 21 of the experiment, the
GI was significantly higher at implants than
Table 1. Protocol of the study
Preparatory phase Plaque accumulation Oral hygiene
Visit 1
(Pre-baseline)
Visit 2
(Baseline)
Visit 3
(PS<20%)
Visit 4 (Day 0,
no hygiene)
Visit 5 (Day 7,
no hygiene)
Visit 6 (Day 14,
no hygiene)
Visit 7 (Day 21,
no hygiene)
Visit 8 (Day 28,
PS<20%)
Visit 9
(Day 42,
PS<20%)
Subject screening X
Informed consent X
Health history,
medications
X X X X X X X X X
Professional
plaque removal
X X X X X X
Oral hygiene
reinforcement
X X X X X
GCF/PCF sampling X X X X X X X
PS X X X X X
PD, BOP, REC X X X X
PI, GI X X X X X X X X
Table 2. Clinical and biological characteristics at the selected study teeth and implants for 20
participants at baseline, expressed as median and interquartile range [IQR]
Teeth Implants P*
Mean PI 0.46 [0.15; 0.77] 0.04 [0.00; 0.33] 0.007
Mean GI 0.00 [0.00; 0.08] 0.00 [0.00; 0.08] 0.60
Mean PD, mm 2.42 [2.21; 2.54] 2.96 [2.75; 3.13] <0.001
Mean BOP 0.08 [0.00; 0.17] 0.17 [0.08; 0.19] 0.07
Mean REC, mm 1.17 [0.81; 1.75] 0.36 [0.00; 0.83] 0.002
IL-1b, pg/ml 145.8 [44.5; 221.7] 89.6 [42.3; 186.6] 0.79
IL-1ra, pg/ml 47.4 [27.1; 508.9] 52.6 [25.0; 512.4] 0.89
IL-6, pg/ml 2.4 [1.4; 12.4] 1.5 [1.1; 6.9] 0.27
IL-8, pg/ml 422.4 [304.3; 681.5] 481.9 [362.3; 870.8] 0.07
IL-17, pg/ml 25.6 [18.3; 31.3] 25.4 [21.9; 38.4] 0.29
Basic-FGF, pg/ml 29.6 [26.8; 32.4] 31.6 [28.9; 38.1] 0.12
G-CSF, pg/ml 716.9 [195.8; 1136.0] 485.2 [121.5; 904.2] 0.24
GM-CSF, pg/ml 43.9 [31.2; 49.1] 47.3 [30.0; 49.8] 0.52
IFN-c, pg/ml 118.3 [86.6; 144.4] 127.2 [94.5; 165.3] 0.20
MIP-1b, pg/ml 13.4 [7.3; 26.8] 19.8 [10.9; 42.1] 0.06
TNF-a, pg/ml 13.0 [7.3; 19.9] 12.2 [9.1; 22.6] 0.07
VEGF, pg/ml 338.6 [231.5; 636.4] 422.5 [334.3; 593.4] 0.30
*Difference between groups.
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teeth. There was a high variability in the pro-
portion of sites with GI >1 among partici-
pants, from day 0 to day 42, as can been seen
in Fig. 4.
PD and REC were significantly higher for
implants than for teeth throughout the study.
PD was slightly but significantly increased in
both groups on day 21. BOP increased signifi-
cantly in both groups with plaque accumula-
tion, more so around implants than around
teeth. At day 42, the BOP had returned to
scores comparable to baseline.
Host-derived parameters
Table 4 shows the concentrations of
biomarkers, expressed in pg/ml before, during
and after plaque accumulation. At day 0, IL-6
was the only biomarker to be significantly
more concentrated in GCF compared to PCF.
During the plaque accumulation phase, the
different biomarkers reacted variably. IL-1b
showed a significantly higher concentration
in both GCF and PCF on days 7, 14, and 21
compared to baseline. Furthermore, GCF con-
centrations were at each time point signifi-
cantly higher than PCF. TNF-a and IFN-c
were significantly higher in GCF compared
to PCF at day 21. Some biomarkers decreased
during the experimental phase: MIP-1b
decreased significantly in GCF at day 7, 14,
and 21, but not in PCF. GCF concentrations
of MIP-1b were significantly lower than in
PCF during the whole experimental phase.
GM-CSF concentrations decreased signifi-
cantly in GCF and PCF compared to baseline,
and there was a significantly higher GM-CSF
concentration in GCF than PCF on day 21.
IL-8 decreased significantly in GCF with pla-
que accumulation on teeth.
In general, after re-establishing oral
hygiene, the level of the different biomarkers
had the tendency to return to the median
concentrations found at baseline within
1 week. On day 28, PCF concentrations of
GM-CSF and IFN-c were still significantly
lower compared to baseline. In GCF, concen-
trations of IL-6, IL-17, GM-CSF, IFN-c, and
MIP-1b were still significantly lower com-
pared to baseline. On day 42, the levels of all
biomarkers assessed in GCF and PCF had
returned to values no longer different from
those measured at day 0.
Discussion
The aim of this study was to compare the
inflammation around dental implants and
natural teeth during and after 3 weeks of
undisturbed plaque accumulation in elderly
Fig. 1. Clinical status of one participant after 21 days
without oral hygiene, showing plaque accumulation
and gingivitis.
Table 3. Clinical parameters before (day 0), during (days 7, 14, 21) and after plaque accumulation (days 28, 42), expressed as median and interquartile
range [IQR]. The GI is dichotomized as 0 or 1 vs. 2 or 3 (GI >1)
Plaque accumulation Oral hygiene
Day 0 Day 7 Day 14 Day 21 Day 28 Day 42
Teeth
Mean PI 0.00 [0.00; 0.08] 1.88 [1.65; 2.08]* 2.42 [2.13; 2.58]* 2.67 [2.31; 2.77]* 0.08 [0.00; 0.17]* 0.13 [0.00; 0.19]*
GI >1 0.00 [0.00; 0.00] 0.17 [0.17; 0.33] 0.42 [0.25; 0.60]* 0.58 [0.42; 0.60]* 0.00 [0.00; 0.02] 0.00 [0.00; 0.02]
Mean PD [mm] 2.38 [2.23; 2.50] – – 2.58 [2.31; 2.67]* – 2.25 [2.08; 2.44]
Mean BOP 0.00 [0.00; 0.02] – – 0.58 [0.48; 0.67]* – 0.04 [0.00; 0.08]
Mean REC [mm] 1.13 [0.65; 1.71] – – 1.21 [0.56; 1.52] – 1.25 [0.48; 1.90]
Implants
Mean PI 0.00 [0.00; 0.00] 1.33 [1.25; 1.52]* 1.83 [1.42; 2.21]* 2.00 [1.56; 2.44]* 0.00 [0.00; 0.08] 0.00 [0.00; 0.08]
GI >1 0.00 [0.00; 0.00] 0.25 [0.17; 0.42] 0.46 [0.31; 0.60]* 0.63 [0.50; 0.75]* 0.00 [0.00; 0.19]* 0.00 [0.00; 0.00]
Mean PD [mm] 2.83 [2.73; 3.08] – – 3.13 [2.88; 3.33]* – 2.75 [2.56; 3.00]
Mean BOP 0.00 [0.00; 0.10] – – 0.71 [0.58; 0.85]* – 0.00 [0.00; 0.17]
Mean REC [mm] 0.29 [0.00; 0.81] – – 0.33 [0.00; 0.85] – 0.21 [0.00; 0.77]
*Significant difference when compared with value at day 0 (P < 0.05).
Values in bold: significant difference between implants and teeth (P < 0.05).
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Fig. 2. Average proportion of sites with PI of 1, 2, and 3. EXM: experimental phase with no oral hygiene; T: teeth;
I: implants.
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persons. Millions of implants are placed
worldwide every year. Given their high docu-
mented survival rates (Andreiotelli et al.
2010; Pjetursson et al. 2012), these implants
will still be in situ when the patients reach
an old and very old age. Physiological aging
implies a functional decline of vision, tactile
sensitivity, and dexterity, rendering meticu-
lous oral hygiene difficult. Furthermore, a
shift in priorities may occur when chronic
diseases and functional impairment dominate
daily life (M€uller 2014). One of the inclusion
criteria of this study was an age of 70 years
or older. In most industrialized countries, the
average life expectancy of men and women
has now risen to over 80 years, and our
experiments would have been even more rel-
evant to a geriatric population if the mini-
mum age had been around 80 years.
However, recruiting in this age cohort proved
difficult, as most patients did either have
implants, or natural teeth, but very rarely
both, as required for the participation in this
study. Furthermore, signs of periodontitis or
peri-implantitis associated with poor oral
hygiene precluded the enrollment of many
otherwise eligible subjects. Nevertheless,
with an average age of 77 years, the cohort in
the present study is still substantially older
than those from previous reports on experi-
mental peri-implantitis and therefore pro-
vides a valuable and novel insight into the
inflammatory tissue reactions in old age.
In agreement with previous studies, there
was evidence for a cause–effect relationship
between plaque accumulation and inflamma-
tion of both the peri-implant mucosa and the
gingiva (Pontoriero et al. 1994; Zitzmann
et al. 2001). Inflammation was clinically
more pronounced around peri-implant tissues
at the end of the experimental phase. After
reintroduction of proper plaque control, all
clinical parameters returned to pre-experi-
mental values. This notion of reversibility
was also in agreement with the literature
(L€oe et al. 1965; Salvi et al. 2012).
At baseline, PI, PD, and REC were signifi-
cantly different between implants and teeth,
with higher values of PD around implants
and higher values of PI and REC around
teeth. Implant restorations often present a
less favorable “self-cleaning” morphology
than natural teeth, due to their reduced
diameter compared to a natural root as well
as various other technical features, rendering
oral hygiene measures more complex. Find-
ing a lower PI on the implant sites seems
therefore counterintuitive, but may be
explained by the increased attention the
patients may have attributed to their
implants, for which they had undergone
numerous treatment sessions and for which
they have spent a substantial amount of
money. A difference of 0.5 mm on PD
between implants and natural teeth has been
shown previously, thus confirming the pre-
sent findings (Christensen et al. 1997). With
the development of mucositis, PD further
increased, in accordance with a previous
study comparing implants with and without
mucositis (Ata-Ali et al. 2013). As for REC,
plaque accumulation did not show any signif-
icant effect in the experiments. This may be
related to the short observation period, where
in terms of recessions, an initial swelling of
the gingiva may have compensated for the
increased PD.
Our clinical results corroborate to those
found by Salvi et al. (2012) who monitored
clinical, microbiological, and host-derived
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Fig. 3. Average proportion of sites with GI of 1, 2, and 3. EXM: experimental phase with no oral hygiene; T: teeth;
I: implants.
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Fig. 4. Proportion of sites with GI >1, from baseline to the end of follow-up time, for each participant. EXM: experi-
mental phase with no oral hygiene.
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alterations around teeth and titanium
implants during the development of experi-
mental gingivitis/mucositis: less plaque accu-
mulation but more inflammation developed
around implants compared to teeth. How-
ever, 3 weeks of resumed plaque control did
not yield pre-experimental levels of gingival
inflammation around implants in their study,
whereas in our trial, inflammation returned
to baseline levels around both implants and
teeth.
We compared the inflammatory response
during a phase of undisturbed plaque accu-
mulation at implants and teeth by analysis of
levels of 12 cytokines in the GCF and PCF.
At baseline, no significant differences were
observed in the expression of any cytokine in
GCF and PCF. This is in accordance with
previous studies that showed that under
healthy clinical conditions, the expression of
biomarkers does not differ between implants
and teeth (Tsalikis 2010; Salvi et al. 2012;
Cionca et al. 2016; Ramseier et al. 2016).
With the development of inflammation, sig-
nificant changes were observed for several
biomarkers assessed around implants and
teeth that returned to baseline levels by the
end of the experiment. The association
between signs of inflammation and the
expression of biochemical markers in GCF
and PCF has been shown previously
(Offenbacher et al. 2010; Petkovic et al.
2010; Guncu et al. 2012; Ramseier et al.
2016).
During the development of gingivitis/mu-
cositis, the most significant difference
between implants and teeth was found for IL-
1b, with higher levels obtained around teeth.
Smaller differences were observed for some
other markers, such as IL-8, GM-CSF, IFN-c,
MIP-1b, and TNF-a. A recent cross-sectional
study in a population with a mean age of
71  9 years reported that IL-1b and IL-8 had
a tendency to be lower in a mucositis group,
when compared to healthy controls (Hall
et al. 2015). Compared to our study, contra-
dictory results were obtained by another
study (Salvi et al. 2012), which found no sig-
nificant differences on the expression of
IL-1b between implants and teeth with the
development of inflammation. Although the
experimental model used in both studies was
similar, the only difference that could explain
these discrepancies is the age of the popula-
tion: their study included subjects between
28 and 75 years old (Salvi et al. 2012),
whereas in our study, all participants were
at least 70 years old. Experimental gingivitis
is comparable but not identical to chronic
gingivitis. As previously reported (Deinzer
et al. 2007), variations in immunological
parameters over 4 weeks of experimental
gingivitis were considerable, whereas only
small fluctuations were observed with
chronic gingivitis. Twenty-one days of exper-
imental gingivitis/mucositis may not be long
enough to discriminate permanent differ-
ences in cytokine profiles around implants
and teeth.
The influence of age on gingival health has
been investigated in several clinical trials.
Some indicated that gingivitis develops more
quickly and is more pronounced in older per-
sons as compared to younger ones (Holm-
Pedersen et al. 1975; Van der Velden 1984;
Fransson et al. 1996). Others found no impact
of age on gingival inflammation. For exam-
ple, GCF flow in young and older subjects
increased similarly during inflammation (Bor-
den et al. 1977). Another experimental gin-
givitis trial showed that age had an effect on
clinical parameters such as plaque and bleed-
ing scores, but had no impact on GCF levels
of studied cytokines; similar levels were
expressed in younger and older persons (Tsa-
likis 2010). When interpreting these findings,
it must be born in mind that the elderly den-
tition more often presents with niches due to
recession of papillae and gingiva and that the
prevalence of dental restorations is also
higher in older age cohorts. Crown margins,
denture clasps and both, fixed and removable
replaced teeth all facilitate plaque adhesion,
Table 4. Biomarkers before (day 0), during (days 7, 14, 21) and after plaque accumulation (days 28, 42). Concentrations are expressed in pg/ml and
are median [IQR]
Plaque accumulation Oral hygiene
Day 0 Day 7 Day 14 Day 21 Day 28 Day 42
Teeth
IL-1b 87.3 [50.6; 115.1] 247.4 [187.4; 443.2]* 311.5 [151.3; 514.2]* 375.1 [252.2; 679.1]* 103.7 [50.1; 205.1] 88.5 [41.4; 208.8]
IL-1ra 45.6 [26.8; 89.2] 108.2 [71.3; 163.1]* 68.6 [49.3; 111.5] 66.6 [35.4; 177.0] 61.3 [27.5; 408.6] 36.0 [21.1; 51.1]
IL-6 4.7 [1.3; 10.0] 1.8 [0.7; 2.6]* 1.7 [1.0; 3.0]* 1.1 [0.7; 2.5]* 1.3 [0.5; 3.1]* 2.6 [0.8; 4.3]
IL-8 429.3 [302.6; 528.2] 242.2 [149.5; 472.0]* 211.4 [144.4; 323.6]* 263.5 [194.9; 348.9] 299.2 [211.5; 478.4] 431.3 [219.0; 664.1]
IL-17 20.3 [14.3; 29.5] 18.9 [12.0; 29.2] 14.6 [0.0; 28.1] 13.3 [0.0; 30.0] 11.7 [0.0; 20.8]* 15.2 [6.8; 25.3]
Basic-FGF 31.7 [27.4; 35.4] 40.1 [32.3; 45.4]* 38.2 [1.7; 48.4] 30.8 [3.8; 39.1] 26.8 [0.0; 34.7] 30.1 [18.0; 41.3]
G-CSF 496.1 [107.3; 1115.9] 443.4 [170.3; 659.5] 236.4 [170.4; 433.7] 259.5 [67.7; 661.4] 273.3 [68.8; 596.3] 363.7 [29.0; 634.6]
GM-CSF 31.8 [20.6; 48.4] 27.3 [16.5; 41.0]* 25.0 [2.6; 40.0] 18.5 [3.6; 41.1]* 26.7 [2.5; 39.9]* 30.1 [20.4; 42.3]
IFN-c 123.2 [75.5; 140.0] 111.5 [103.0; 163.9] 106.1 [47.9; 148.8] 92.3 [61.5; 120.2] 79.2 [15.8; 92.1]* 97.9 [52.9; 116.9]
MIP-1b 17.8 [7.6; 27.8] 5.3 [3.4; 8.5]* 4.7 [2.7; 6.6]* 4.4 [3.1; 7.1]* 6.1 [4.3; 15.3]* 10.7 [7.9; 18.4]
TNF-a 11.1 [6.4; 20.5] 12.8 [8.7; 19.4] 10.4 [6.3; 18.6] 9.6 [5.8; 17.0] 7.2 [3.2; 11.6] 8.6 [5.7; 24.1]
VEGF 391.0 [260.8; 470.6] 339.7 [293.2; 558.2] 351.2 [284.0; 528.4] 317.8 [244.1; 725.0] 235.8 [138.1; 368.3] 340.8 [159.3; 474.3]
Implants
IL-1b 80.9 [38.0; 146.0] 161 [76.3; 331]* 166.8 [116.6; 249.4]* 163.4 [81.0; 288.0]* 81.7 [44.2; 132.2] 86.1 [62.5; 228.2]
IL-1ra 61.5 [31.5; 213.5] 125.1 [36.7; 186]* 103.0 [50.8; 179.7] 54.2 [33.6; 119.6] 75.7 [39.1; 104.6] 44.9 [27.5; 73.3]
IL-6 1.9 [1.0; 5.6] 1.8 [0.83; 2.74] 1.3 [0.5; 2.4]* 1.6 [0.3; 2.4] 1.3 [0.9; 2.1] 1.8 [0.5; 6.6]
IL-8 419.8 [232.6; 904.3] 392 [224; 878] 394.4 [222.5; 486.8] 231.3 [168.8; 551.9] 359.3 [220.6; 523.1] 498.6 [184.6; 823.5]
IL-17 19.4 [12.6; 28.9] 22.1 [9.44; 32.7] 11.3 [0.0; 30.7] 3.5 [0.0; 20.6] 11.8 [0.0; 25.3] 14.2 [1.5; 23.6]
Basic-FGF 31.3 [27.0; 35.3] 37.7 [28.9; 44] 34.7 [0.01; 52.4] 19.2 [0.3; 35.7] 22.0 [0.0; 40.6] 34.0 [13.9; 36.5]
G-CSF 257.3 [149.4; 667.0] 263 [108; 561] 192.5 [41.0; 404.3] 65.9 [9.1; 259.8]* 35.9 [8.9; 395.9] 220.5 [18.3; 432.4]
GM-CSF 34.2 [20.7; 47.3] 25.9 [15; 36.5]* 17.2 [2.2; 39.2]* 7.9 [1.1; 35.6]* 21.0 [2.8; 39.5]* 30.7 [12.3; 40.5]
IFN-c 92.4 [80.7; 129.3] 119 [68.8; 143] 89.4 [26.8; 140.4] 56.6 [25.1; 88.1] 54.5 [17.1; 104.3]* 92.6 [26.0; 126.4]
MIP-1b 12.6 [7.1; 26.8] 11.9 [6.84; 21.5] 7.5 [4.8; 19.2] 8.3 [3.9; 26.1] 12.3 [6.1; 24.1] 12.1 [8.1; 29.4]
TNF-a 7.1 [5.7; 17.8] 11.8 [8.12; 17.5] 9.4 [2.7; 13.2] 8.7 [2.3; 12.3] 7.6 [3.6; 15.8] 14.6 [3.0; 27.6]
VEGF 400.2 [211.1; 564.8] 368 [212; 702] 396.1 [218.2; 645.3] 328.0 [156.8; 506.5] 157.1 [127.6; 374.9] 303.6 [141.6; 444.6]
*Significant difference when compared with value at day 0 (P < 0.05).
Values in bold: significant difference between implants and teeth (P < 0.05).
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thus explaining the increased plaque and
bleeding scores.
Immunosenescence renders elderly individ-
uals more prone to infections, but these are
less often acute than in younger persons. A
review (Hajishengallis 2010) showed that
phagocytosis declines with age, thus empha-
sizing that age affects the immune system.
On the whole, even if there are limited num-
bers of studies dealing with the effect of age
on neutrophils, it seems that their function
and capacity to chemotaxis can be affected as
well (Butcher et al. 2000; Scott & Krauss
2012).
In summary, the present study has shown
in persons aged 70 or over that plaque accu-
mulation induces an inflammatory reaction
around both teeth and implants. Although
there was less plaque accumulation on
implants, the peri-implant mucosa showed a
stronger clinical response than gingiva. A
cause-and-effect relationship was confirmed.
On a biomarker level, IL-1b was found to
increase significantly around both implants
and teeth. The significantly higher expression
of IL-1b, TNF-a, IFN-c, and GM-CSF around
teeth contrasted the higher GI scores at
implants. Experimental gingivitis and
mucositis were reversible both clinically and
biochemically.
It can therefore be concluded that meticu-
lous oral hygiene remains important in old
age, for both, natural teeth and implant
restorations. The reported higher susceptibil-
ity of the peri-implant tissues to signs and
symptoms of inflammation compared to the
periodontal tissues of natural teeth requires
an even tighter and lifelong recall regimen
to assure oral hygiene and peri-implant
health.
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